About 6-[(4R)-4-[8-[3-[5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanylanilino]-8-oxooctoxy]-3,3-difluoropyrrolidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]methyl]pyridazine-3-carboxamide
6-[(4R)-4-[8-[3-[5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanylanilino]-8-oxooctoxy]-3,3-difluoropyrrolidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]methyl]pyridazine-3-carboxamide (PubChem CID 172513962) has the molecular formula C47H55F2N11O6S
and a molecular weight of 940.09 g/mol. Its IUPAC name is 6-[(4R)-4-[8-[3-[5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanylanilino]-8-oxooctoxy]-3,3-difluoropyrrolidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]methyl]pyridazine-3-carboxamide.
Analyze 6-[(4R)-4-[8-[3-[5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanylanilino]-8-oxooctoxy]-3,3-difluoropyrrolidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]methyl]pyridazine-3-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 6-[(4R)-4-[8-[3-[5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanylanilino]-8-oxooctoxy]-3,3-difluoropyrrolidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]methyl]pyridazine-3-carboxamide?
The IUPAC name of 6-[(4R)-4-[8-[3-[5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanylanilino]-8-oxooctoxy]-3,3-difluoropyrrolidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]methyl]pyridazine-3-carboxamide (CID 172513962) is 6-[(4R)-4-[8-[3-[5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanylanilino]-8-oxooctoxy]-3,3-difluoropyrrolidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]methyl]pyridazine-3-carboxamide.
What is the SMILES notation for 6-[(4R)-4-[8-[3-[5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanylanilino]-8-oxooctoxy]-3,3-difluoropyrrolidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]methyl]pyridazine-3-carboxamide?
The canonical SMILES for 6-[(4R)-4-[8-[3-[5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanylanilino]-8-oxooctoxy]-3,3-difluoropyrrolidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]methyl]pyridazine-3-carboxamide is CC1(N)CCN(c2cnc(Sc3cccc(NC(=O)CCCCCCCO[C@@H]4CN(c5ccc(C(=O)NCc6ccc7c(c6)CN(C6CCC(=O)NC6=O)C7=O)nn5)CC4(F)F)c3)cn2)CC1.
What is the InChIKey of 6-[(4R)-4-[8-[3-[5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanylanilino]-8-oxooctoxy]-3,3-difluoropyrrolidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]methyl]pyridazine-3-carboxamide?
The InChIKey is MWTDTCMZDCWGIV-SLKOVYPGSA-N. The full InChI is InChI=1S/C47H55F2N11O6S/c1-46(50)17-19-58(20-18-46)39-25-52-42(26-51-39)67-33-9-7-8-32(23-33)54-40(61)10-5-3-2-4-6-21-66-37-28-59(29-47(37,48)49)38-15-13-35(56-57-38)43(63)53-24-30-11-12-34-31(22-30)27-60(45(34)65)36-14-16-41(62)55-44(36)64/h7-9,11-13,15,22-23,25-26,36-37H,2-6,10,14,16-21,24,27-29,50H2,1H3,(H,53,63)(H,54,61)(H,55,62,64)/t36?,37-/m1/s1.
What are the key properties of 6-[(4R)-4-[8-[3-[5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanylanilino]-8-oxooctoxy]-3,3-difluoropyrrolidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]methyl]pyridazine-3-carboxamide?
6-[(4R)-4-[8-[3-[5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanylanilino]-8-oxooctoxy]-3,3-difluoropyrrolidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]methyl]pyridazine-3-carboxamide has a molecular weight of 940.09 g/mol, XLogP of 5.25, 18 rotatable bonds, 4 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[(4R)-4-[8-[3-[5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanylanilino]-8-oxooctoxy]-3,3-difluoropyrrolidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]methyl]pyridazine-3-carboxamide is sourced from PubChem (CID 172513962), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).